Evidence map›Paper›PMID 40240456›Full record

ArticleScientific reports2025

Analysis of the bronchoalveolar lavage fluid microbial flora in COPD patients at different lung function during acute exacerbation.

Kawsar Bahetjan, Yu-Xia, Shijun Lin, Nuerziba Aili, Haiyan Yang, Shijun Du

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kawsar BahetjanRespiratory and Respiratory Critical Care Center, School of Medicine, The Second Affiliated Hospital, The Chinese University of Hong Kong, Shenzhen, 518172, China.
Yu-XiaSecond Ward, Respiratory and Respiratory Critical Care Center, First Affiliated Hospital of Xinjiang Medical University, Urumchi, 830011, China. xiayuxj@yeah.net.
Shijun LinRespiratory and Respiratory Critical Care Center, School of Medicine, The Second Affiliated Hospital, The Chinese University of Hong Kong, Shenzhen, 518172, China.
Nuerziba AiliSecond Ward, Respiratory and Respiratory Critical Care Center, First Affiliated Hospital of Xinjiang Medical University, Urumchi, 830011, China.
Haiyan YangSecond Ward, Respiratory and Respiratory Critical Care Center, First Affiliated Hospital of Xinjiang Medical University, Urumchi, 830011, China.
Shijun DuSecond Ward, Respiratory and Respiratory Critical Care Center, First Affiliated Hospital of Xinjiang Medical University, Urumchi, 830011, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a correlation between the dysbiosis of the respiratory microbiota and the occurrence, severity, frequency, and mortality of Chronic Obstructive Pulmonary Disease (COPD). However, it is not unclear if there are differences in the bronchoalveolar lavage fluid (BALF) microbiota among patients at differente lung function. In this study, BALF samples were collected from 70 COPD patients experiencing acute exacerbations (AECOPD). The patients were divided into a mild group (FEV1/pre ≥ 50; PFT I, n = 50) and a severe group (FEV1/pre < 50; PFT II, n = 20) according to the lung function: or a frequent exacerbation (FE, n = 41) group and a non-frequent exacerbation (NFE, n = 29) group according to their exacerbation history. Microbiota analysis of BALF samples was conducted using mNGS and bioinfromatic analysis. Compared to PFT I group, PFT II group exhibited a significant decrease in species diversity (Shannon index), as well as a significant reduction in total species count and richness (Chao1, ACE indices). NFE group demonstrated diversity similar to that of FE group. Conversely, the microbial diversity of NFE group was comparable to that of FE group. The most abundant bacterial genera were Streptococcus, Prevotella, Veillonella, Rod-shaped Bacillus, and Rothia. Aspergillus was the most dominant fungal genus in AECOPD. Lymphocryptovirus was the most prevalent virus in AECOPD.Compared to the PFT I group, Corynebacterium's abundance significantly increased in PFT II group. Furthermore, FE group showed a notable increase in Streptococcus mitis abundance relative to NFE group. Bubble plot analysis revealed a significant increase in Moraxella, Fusobacterium, Haemophilus, Pseudomonas, Streptomyces, and Klebsiella in PFT II group, including a notable increase in typical Veillonella, Actinomyces, and Gordonia. The NFE group exhibited a significant increase in Bacteroides and Prevotella's relative abundance. Spearman correlation analysis revealed strong positive correlations among certain microbial communities. There exists a significant variation in microbial composition across groups of AECOPD patients at different lung function. Specifically, patients with severe airflow limitations exhibit a significant reduction in microbial diversity. Additionally, distinct bacterial taxa are enriched in patients characterized by varying levels of airflow limitation and exacerbation frequency. These observations offer vital insights into the pathogenesis of AECOPD, suggesting a potentially crucial role for the microbiota in its development. Such findings pave the way for identifying potential therapeutic targets and intervention strategies, ultimately aiming to improve treatment outcomes for AECOPD patients.

Indexed as

Bronchoalveolar Lavage FluidLungMicrobiotaPulmonary Disease, Chronic ObstructiveAgedBacteriaDysbiosisFemaleHumansMaleMiddle AgedAcute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)Bronchoalveolar Lavage Fluid (BALF)Exacerbation frequencyLung functionMetagenomic next-Generation Sequencing (mNGS)Microbiome

Identifiers

PMID40240456
PMCPMC12003667

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.